199 related articles for article (PubMed ID: 7478426)
1. Mitoxantrone, fluorouracil plus L-leucovorin, and vinorelbine in pretreated advanced breast cancer.
Colleoni M; Nelli P; Gaion F; Sgarbossa G; Manente P
Oncology; 1995; 52(6):435-8. PubMed ID: 7478426
[TBL] [Abstract][Full Text] [Related]
2. Is salvage chemotherapy for metastatic breast cancer always effective and well tolerated? A phase II randomized trial of vinorelbine versus 5-fluorouracil plus leucovorin versus combination of mitoxantrone, 5-fluorouracil plus leucovorin.
Venturino A; Comandini D; Simoni C; Merlini L; Naso C; Palumbo R; Fusco V; Porcile G; Pronzato P; Rosso R; Repetto L
Breast Cancer Res Treat; 2000 Apr; 60(3):195-200. PubMed ID: 10930106
[TBL] [Abstract][Full Text] [Related]
3. Mitoxantrone plus vinorelbine in pretreated patients with metastatic breast cancer.
Onyenadum A; Gogas H; Markopoulos C; Bafaloukos D; Aravantinos G; Mantzourani M; Koutras A; Tzorakoelefterakis E; Xiros N; Makatsoris T; Fountzilas G; Kalofonos HP
J Chemother; 2007 Oct; 19(5):582-9. PubMed ID: 18073159
[TBL] [Abstract][Full Text] [Related]
4. Effective treatment of advanced breast cancer with vinorelbine, 5-fluorouracil and l-leucovorin plus human granulocyte colony-stimulating factor.
Kornek GV; Haider K; Kwasny W; Lang F; Krauss G; Hejna M; Raderer M; Weinländer G; Depisch D; Scheithauer W
Br J Cancer; 1998 Sep; 78(5):673-8. PubMed ID: 9744509
[TBL] [Abstract][Full Text] [Related]
5. Activity of combination chemotherapy in brain metastases from breast and lung adenocarcinoma.
Colleoni M; Graiff C; Nelli P; Vicario G; Sgarbossa G; Pancheri F; Manente P
Am J Clin Oncol; 1997 Jun; 20(3):303-7. PubMed ID: 9167759
[TBL] [Abstract][Full Text] [Related]
6. A phase II study of cisplatin, 5-fluorouracil, and leucovorin augmented by vinorelbine (Navelbine) for advanced non-small cell lung cancer: rationale and study design.
Vokes EE; Drinkard LC; Samuels BL; Hoffman PC; Watson S; Bitran JD; Haraf DJ; Ferguson MF; Golomb HM
Semin Oncol; 1994 Oct; 21(5 Suppl 10):79-83; discussion 83-4. PubMed ID: 7973772
[TBL] [Abstract][Full Text] [Related]
7. Preliminary report on a phase I study of ifosfamide and vinorelbine (navelbine) in advanced non-small cell lung cancer.
Masters GA; Hoffman PC; Drinkard LC; Watson S; Samuels BL; Golomb HM; Vokes EE
Semin Oncol; 1996 Apr; 23(2 Suppl 5):11-8. PubMed ID: 8610230
[TBL] [Abstract][Full Text] [Related]
8. A phase I-phase II study of vinorelbine with cisplatin, 5-fluorouracil, and leucovorin for advanced non-small cell lung cancer.
Masters GA; Drinkard LC; Hoffman PC; Lane N; Watson S; Samuels BL; Bitran JD; Golomb HM; Vokes EE
Cancer J Sci Am; 1995; 1(4):288-94. PubMed ID: 9166490
[TBL] [Abstract][Full Text] [Related]
9. Five-day infusion of fluorouracil and vinorelbine for advanced breast cancer patients treated previously with anthracyclines.
Pieńkowski T; Jagiello-Gruszfeld A
Int J Clin Pharmacol Res; 2001; 21(3-4):111-7. PubMed ID: 12067140
[TBL] [Abstract][Full Text] [Related]
10. Mitoxantrone, L-leucovorin and 5-fluorouracil: an effective and well tolerated first-line treatment for advanced breast cancer.
Lorusso V; Mancarella S; Catino A; Brandi M; Paradiso A; Latorre A; Mastria A; De Mitrio A; Guida M; De Lena M
Tumori; 1999; 85(1):60-4. PubMed ID: 10228500
[TBL] [Abstract][Full Text] [Related]
11. Phase I-II study of vinorelbine in combination with 5-fluorouracil and folinic acid as first-line chemotherapy in metastatic breast cancer: a regimen with a low subjective toxic burden.
Nolè F; de Braud F; Aapro M; Minchella I; De Pas TM; Zampino MG; Monti S; Andreoni G; Goldhirsch A
Ann Oncol; 1997 Sep; 8(9):865-70. PubMed ID: 9358936
[TBL] [Abstract][Full Text] [Related]
12. Paclitaxel and 5-fluorouracil in metastatic breast cancer: the US experience.
Paul DM; Garrett AM; Meshad M; DeVore RD; Porter LL; Johnson DH
Semin Oncol; 1996 Feb; 23(1 Suppl 1):48-52. PubMed ID: 8629038
[TBL] [Abstract][Full Text] [Related]
13. Phase I studies of fluorouracil, doxorubicin and vinorelbine without (FAN) and with (SUPERFAN) folinic acid in patients with advanced breast cancer.
Goss PE; Fine S; Gelmon K; Rudinskas L; Ottaway J; Myles J; James K; Paul K; Rodgers A; Pritchard KI
Cancer Chemother Pharmacol; 1997; 41(1):53-60. PubMed ID: 9443614
[TBL] [Abstract][Full Text] [Related]
14. Paclitaxel in combination with vinorelbine in pretreated advanced breast cancer patients.
Michelotti A; Gennari A; Salvadori B; Giannessi PG; Baldini E; Tibaldi C; Da Prato M; Conte PF
Semin Oncol; 1996 Oct; 23(5 Suppl 11):38-40. PubMed ID: 8893898
[TBL] [Abstract][Full Text] [Related]
15. Treatment of previously treated metastatic breast cancer by mitoxantrone and 48-hour continuous infusion of high-dose 5-FU and leucovorin (MFL): low palliative benefit and high treatment-related toxicity.
Yen CC; Tung SL; Hsieh RK; Chiou TJ; Liu JH; Wang WS; Chen PM
Jpn J Clin Oncol; 1997 Oct; 27(5):316-20. PubMed ID: 9390208
[TBL] [Abstract][Full Text] [Related]
16. Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer.
Klaassen U; Wilke H; Seeber S
Semin Oncol; 1996 Oct; 23(5 Suppl 11):32-7. PubMed ID: 8893897
[TBL] [Abstract][Full Text] [Related]
17. A phase II trial of mitoxantrone plus cyclophosphamide and 5-fluorouracil in modulation with levo-folinate for advanced breast cancer patients.
Leonardi V; Meli M; Palmeri S; Russo A; Rini GB; Peralta S; Rausa L
J Chemother; 1995 Apr; 7(2):160-6. PubMed ID: 7545224
[TBL] [Abstract][Full Text] [Related]
18. First-line treatment of metastatic breast cancer with mitoxantrone, vinorelbine, and carboplatin.
Kakolyris S; Kourousis C; Koukourakis M; Androulakis N; Vamvakas L; Agelaki S; Hatzidaki D; Samonis G; Tsiftsis D; Georgoulias V
Am J Clin Oncol; 1999 Dec; 22(6):568-72. PubMed ID: 10597740
[TBL] [Abstract][Full Text] [Related]
19. Combination cisplatin-vinorelbine for relapsed and chemotherapy-pretreated metastatic breast cancer.
Shamseddine AI; Taher A; Dabaja B; Dandashi A; Salem Z; El Saghir NS
Am J Clin Oncol; 1999 Jun; 22(3):298-302. PubMed ID: 10362341
[TBL] [Abstract][Full Text] [Related]
20. Mitoxantrone, 5-fluorouracil, and high dose leucovorin (NFL) versus intravenous cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in first-line chemotherapy for patients with metastatic breast carcinoma: a randomized phase II trial.
Hainsworth JD; Jolivet J; Birch R; Hopkins LG; Greco FA
Cancer; 1997 Feb; 79(4):740-8. PubMed ID: 9024712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
